PAKISTAN
Highnoon Laboratories Limited has announced the groundbreaking of its new greenfield manufacturing expansion project, titled Project FORCE, marking a significant step toward strengthening Pakistan’s pharmaceutical manufacturing capacity.
According to a notice submitted to the Pakistan Stock Exchange (PSX), the groundbreaking ceremony was held on January 22, 2026, at the Special Economic Zone (SEZ), Quaid-e-Azam Business Park, Sheikhupura.
Project FORCE is aimed at establishing a world-class, efficient, and globally compliant pharmaceutical manufacturing facility in Pakistan. The new plant is expected to enhance Highnoon Laboratories’ manufacturing footprint, support future growth, and improve the company’s ability to cater to both domestic and export markets in line with internationally recognized quality and regulatory standards.
The company said the initiative reflects its long-term strategic vision to invest in modern infrastructure and operational excellence, contributing to sustainable growth amid an increasingly competitive global pharmaceutical landscape. – ER News Desk
READ MORE
China’s Robot Trainers Turn Household Chores into AI Training Data
Across China, a growing number of freelance workers are training robots by performing everyday household…
AI Safety Concerns Dominate Dublin Summit as Experts Warn of Emerging Threats
Artificial intelligence safety emerged as a major concern at an industry summit in Dublin on…
40 Major Media Groups Join Coalition to Protect Journalism from AI Copyright Violations
Forty major media organisations, including The New York Times, The Economist and Agence France-Presse (AFP),…
Zong Launches 5G Home Broadband Service in Pakistan
Zong has launched Z HomeFi, a 5G fixed wireless access (FWA) home broadband service, aiming…
BYD Eyes Ultra-Fast EV Charging Technology for Pakistan
Chinese electric vehicle (EV) manufacturer BYD is in discussions with its Pakistani partner, Mega Motor…
Game-Based Digital Therapies Show Mixed Results in Treating Children with ADHD
Stimulant medications are among the most common treatments for children with attention-deficit/hyperactivity disorder (ADHD), helping…